CogniHab
Cognihab is a health-tech organization that uses immersive Virtual Reality (VR) technology to deliver innovative healthcare
About
At Cognihab, we are dedicated to expanding the horizons of digital health through evidence-based insights and interactive recovery tools. Our comprehensive library covers diverse clinical applications, including Inside the Technology Powering VR Cancer Rehabilitation for Chemotherapy Patients and The Shared Blueprint Behind Joint Recovery and Pediatric Motor Therapy. We also address modern lifestyle challenges with guides like Is Your Desk Job Quietly Wrecking Your Spine?, Why Office Workers Keep Losing the Battle With Back Pain, and Your Chair Isn't the Problem, Your Habits Are.
To ensure safety and efficacy, we address key questions in Is VR Therapy Safe or Just Another Health Trend?, Before You Try VR Therapy, Ask This One Question First, and The Honest Truth About VR Therapy Safety. Additionally, explore our wellness solutions in VR Relaxation: Do People Really Use It to Relax? to discover how immersive technology enhances daily mental rejuvenation.
Ready to launch?
Submit your product and get discovered by builders and creators worldwide.
Launch Now
FounderPlaybooks.
What other founders did to grow.
2722 dispatches from hundreds of founders, pulled from the week's best podcasts.
Subscription wasn't big for us at the time right now it's most of our revenue and the company 3x or 4X because we properly took the time to like focus on subscription and at the time it was mostly ads and subscription was something that we had but just for the handful of people that wanted to remove the ads.
Ads-to-subscription pivot 3–4× revenue — the hidden subscription was already converting, just buried
Podcast App ran on ads with a nearly invisible subscription (remove-ads upsell). When Siniawski properly invested in subscription — surfacing the offer, improving the paywall, using RevenueCat — the company's revenue tripled or quadrupled. The lesson: if subscription is already converting for a small segment without any optimization, that's a strong signal that focused paywall investment will compound dramatically.
Sean Ellis developed a simple test: if you were no longer able to use this product today, how disappointed would you be — very disappointed, somewhat, or not? The golden benchmark is 40%. Like Superhuman did, you can segment that data to find the nucleus of your highest-intent users and use it to build a product roadmap that moves you over the line.
Use the 40% disappointment test to quantify product-market fit — not just 'feel it when you see it'
The binary 'you'll know it when you see it' PMF definition is not actionable. The 40% threshold gives a directional score that can be tracked over time and segmented by user type. Superhuman ran this test iteratively — found they were below 40%, identified which segments were closest, talked to those users, built toward their needs, and systematically crossed the threshold.
There's a play for whatever you're stuck on.
Read all 2722 playbooks